MELBOURNE, Australia, Sept. 28 /PRNewswire-FirstCall/ -- Prana Biotechnology Limited (NasdaqCM: PRAN) (ASX: PBT.AX - News), a biopharmaceutical company focused on the research and development of treatments for neurodegenerative disorders, today announced it has filed its annual report containing audited consolidated financial statements for the year ended June 30, 2007, with the U.S. Securities and Exchange Commission. The annual report its available on Prana’s website (www.pranabio.com). Shareholders may receive a hard copy of the annual report free of charge upon request.
